bafna-pharmaceuticals-ltd
Home
Bafna Pharmaceuticals Ltd
BAFNAPH Share Price
BSE:
NSE:BAFNAPH
BAFNAPH Share Price
BSE:
NSE:BAFNAPH
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹191.62 Cr
PE Ratio
253.13
Bafna Pharmaceuticals Ltd Performance
▲
▲
▲
▲
Bafna Pharmaceuticals Ltd Fundamentals
Bafna Pharmaceuticals Ltd Delivery and Volume
About Bafna Pharmaceuticals Ltd
Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and has been engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit w
| Name | Designation |
|---|---|
| Babulal Kamlesh Kumar | Non-Exec. & Independent Dir. |
| Shanmugam Hemalatha | Chairperson / Executive Director |
| Akilapriya Chandrashekar Raju | Non-Exec & Non-Independent Dir |
| Palamadai Krishnan Sundaresan | Non-Exec. & Independent Dir. |
| Ravichandran Chitra | Non-Exec. & Independent Dir. |
| Upendar Mekala Reddy | Non Executive Director |
| Krishna Yeachuri | Independent Director |
| Vinayak Dinesh Dendukuri | Whole-time Director |
| A Mohanachandran | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Bafna Pharmaceuticals Ltd FAQs
How do I Buy Bafna Pharmaceuticals Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Bafna Pharmaceuticals Ltd shares in BlinkX.
What is the Share Price of Bafna Pharmaceuticals Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Bafna Pharmaceuticals Ltd's share price is ₹80.71 as of 2024-12-15.
What is the PE ratio of Bafna Pharmaceuticals Ltd?
Bafna Pharmaceuticals Ltd's P/E ratio is 253.13 times as of 2024-12-15.
What is the PB ratio of Bafna Pharmaceuticals Ltd?
Bafna Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 2.32, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Bafna Pharmaceuticals Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Bafna Pharmaceuticals Ltd's market capitalization is ₹191.62 Cr as on 2024-12-15.
What is the ROE of Bafna Pharmaceuticals Ltd?
The current financial records of Bafna Pharmaceuticals Ltd show a 5.74% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Bafna Pharmaceuticals Ltd?
According to Bafna Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹94.47, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Bafna Pharmaceuticals Ltd?
The 52-week high/low price of a Bafna Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Bafna Pharmaceuticals Ltd's 52-week high and low as of 2024-12-15 are ₹84.14 and ₹80.5, respectively.
